Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxilan for Postoperative Complications in Wisdom Teeth Removal
NCT05142449Phase 4Completed
- Sponsor
- Medical University of Graz
- Start
- Mar 2019
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative complications comparing Amoxilan with Placebo (2 arms). Primary endpoint: Change of interincisal distance. Started Mar 2019; status: completed.
02
Drugs
amoxicillin
03
Conditions
postoperative complications
Beyond the preview
Go deeper on NCT05142449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05142449.